Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh

Tuberculosis

Volumn 92, Issue 6, 2012, Pages 529-534

  Rahim, Zeaur ^a   Nakajima, Chie ^b   Raqib, Rubhana ^a   Zaman, Khalequ ^a   Endtz, Hubert P ^a   Van Der Zanden, Adri G M ^c   Suzuki, Yasuhiko ^b,d  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Enscheda Hospital   (Netherlands)

^d JST/JICA SATREPS ^*  (Japan)

Author keywords

Bangladesh; Isoniazid; Mycobacterium tuberculosis; Resistance; Rifampicin

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; ISONIAZID; RIFAMPICIN; THREONINE;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BANGLADESH; CODON; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; GENE MUTATION; GENE SEQUENCE; HOSPITAL PATIENT; MOLECULAR MECHANICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BANGLADESH; CATALASE; CODON; DRUG RESISTANCE, BACTERIAL; EARLY DIAGNOSIS; FEMALE; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; PHYLOGENY; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84867331428     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2012.07.005     Document Type: Article

References (53)

1. M.C. Raviglione, D.E. Snider Jr., and A. Kochi Global epidemiology of tuberculosis: Mortality and morbidity of a worldwide epidemic JAMA 273 1995 220 226
2. World Health Organization Global tuberculosis control 2011 http://www.who.int/tb/publications/global-report/2011/gtbr11-full.pdf
3. E. Nathanson, P. Nunn, M. Uplekar, K. Floyd, E. Jaramillo, K. Lönnroth, D. Weil, and M. Raviglione MDR tuberculosis-critical steps for prevention and control N Engl J Med 363 2010 1050 1058
4. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDRTB): 2010 global report on surveillance and response. http://whqlibdoc. who.int/publications/2010/9789241599191-eng.
5. A. van Deun, K.J. Aung, S. Chowdhury, S. Saha, A. Pankaj, A. Ashraf, L. Rigouts, K. Fissette, and F. Portaels Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regiments Int J Tuberc Lung Dis 3 1999 143 148
6. K. Zaman, Z. Rahim, M. Yunus, S. Arifeen, A. Baqui, D. Sack, S. Hossain, S. Banu, M.A. Islam, J. Ahmed, R. Breiman, and R. Black Drug resistance of Mycobacterium tuberculosis in rural and urban areas in Bangladesh Scand J Infect Dis 37 2005 21 26
7. S. Ramaswamy, and J.M. Musser Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: update Tuber Lung Dis 79 1998 3 29
8. S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K. Eiglmeier, S. Gas, C.E. Barry 3rd, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M.A. Quail, M.A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J.E. Sulston, K. Taylor, S. Whitehead, and B.G. Barrell Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Nature 393 1998 537 544
9. K. Lewis Multidrug resistance pumps in bacteria: variations on a theme Trend Biochem Sci 19 1994 119 123
10. M.D. Nettleman Multidrug-resistant tuberculosis: news from the front JAMA 293 2005 2788 2790
11. World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug resistant tuberculosis (MDR-TB). Policy statement. http://www.who.int/tb/dots/laboratory/line-probe-assays/en/ index.html.
12. A. Sajduda, A. Brzostek, M. Poplawska, E. Augustynowicz-Kopec, Z. Zwolska, S. Niemann, J. Dziadek, and D. Hillemann Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland J Clin Microbiol 42 2004 2425 2431
13. A. Telenti, P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M.J. Colston, L. Matter, K. Schopfer, and T. Bodmer Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis Lancet 341 1993 647 650
14. Y. Zhang, and W.W. Yew Mechanisms of drug resistance in Mycobacterium tuberculosis Int J Tuberc Lung Dis 13 2009 1320 1330
15. M.H. Hazbón, M. Brimacombe, M. Bobadilla del Valle, M. Cavatore, M.I. Guerrero, M. Varma-Basil, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. García-García, C.I. León, M. Bose, F. Chaves, M. Murray, K.D. Eisenach, J. Sifuentes-Osornio, M.D. Cave, A. Ponce de León, and D. Alland Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis Antimicrob Agents Chemother 50 2006 2640 2649
16. P. Kiepiela, K.S. Bishop, A.N. Smith, L. Roux, and D.F. York Genomic mutations in the katG, inhA, and ahpC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa Tuber Lung Dis 80 2000 47 56
17. M. Zhang, J. Yue, Y.P. Yang, H.M. Zhang, J.Q. Lei, R.L. Jin, X.L. Zhang, and H.H. Wang Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China J Clin Microbiol 43 2005 5477 5482
18. S.A. Petroff A new and rapid method for the isolation and cultivation of tubercle bacilli directly from the sputum and faeces J Exp Med 21 1915 38 42
19. G. Canetti, W. Fox, A. Khomenko, H.T. Mahler, N.K. Menon, D.A. Mitchison, N. Rist, and N.A. Šmelev Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes Bull WHO 41 1969 21 43
20. C. Nakajima, Z. Rahim, Y. Fukushima, I. Sugawara, A.G. van der Zanden, A. Tamaru, and Y. Suzuki Identification of Mycobacterium tuberculosis clinical isolates in Bangladesh by a species distinguishable multiplex PCR BMC Infect Dis 10 2010 118
21. A. Hall BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT Nucleic Acids Symp Ser 41 1999 95 98
22. A. Poudel, C. Nakajima, Y. Fukushima, H. Suzuki, B.D. Pandey, B. Maharjan, and Y. Suzuki Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal Antimicrob Agents Chemother 56 2012 2831 2836
23. M. Kourout, I. Chaoui, R. Sabouni, O. Lahlou, M. El Mzibri, A. Jordaan, T.C. Victor, M. Akrim, and R. El Aouad Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Morocco Int J Tuberc Lung Dis 13 2009 1440 1442
24. A.S. Lee, I.H. Lim, L.L. Tang, and S.Y. Wong High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore J Clin Microbiol 43 2005 2026 2027
25. T. Prammananan, W. Cheunoy, D. Taechamahapun, J. Yorsangsukkamol, S. Phunpruch, P. Phdarat, M. Leechawengwong, and A. Chaiprasert Distribution of rpoB mutations among multidrug-resistant Mycobacterium tuberculosis (MDRTB) strains from Thailand and development of a rapid method for mutation detection Clin Microbiol Infect 14 2008 446 453
26. A.R. Valim, M.L. Rossetti, M.O. Ribeiro, and A. Zaha Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil J Clin Microbiol 38 2000 3119 3122
27. N.N. Minh, N. Van Bac, N.T. Son, V.T. Lien, C.H. Ha, N.H. Cuong, C.T. Mai, and T.H. Le Molecular characteristics of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Vietnam J Clin Microbiol 50 2012 598 601
28. Z. Bártfai, A. Somoskövi, C. Ködmön, N. Szabó, E. Puskás, L. Kosztolányi, E. Faragó, J. Mester, L.M. Parsons, and M. Salfinger Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay J Clin Microbiol 39 2001 3736 3739
29. J. Paluch-Oles, M. Kozioł-Montewka, and A. Magrys Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates from Eastern Poland New Microbiol 32 2009 147 152
30. J. Sheng, J. Li, G. Sheng, H. Yu, H. Huang, H. Cao, Y. Lu, and X. Deng Characterization of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis from eastern China J Appl Microbiol 105 2008 904 911
31. D. Hillemann, T. Kubica, S. Rüsch-Gerdes, and S. Niemann Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany Antimicrob Agents Chemother 49 2005 1229 1231
32. M.J. Torres, A. Criado, N. Gónzalez, J.C. Palomares, and J. Aznar Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain Int J Tuberc Lung Dis 6 2002 160 163
33. M. Heep, B. Brandstätter, U. Rieger, N. Lehn, E. Richter, S. Rüsch-Gerdes, and S. Niemann Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates J Clin Microbiol 39 2001 107 110
34. K. Hirano, C. Abe, and M. Takahashi Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay J Clin Microbiol 37 1999 2663 2666
35. J. Hui, N. Gordon, and R. Kajioka Permeability barrier to rifampin in mycobacteria Antimicrob Agents Chemother 11 1977 773 779
36. D.A. Rouse, J.A. DeVito, Z. Li, H. Byer, and S.L. Morris Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance Mol Microbiol 22 1996 583 592
37. G. Aslan, S. Tezcan, M.S. Serin, and G. Emekdas Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey Jpn J Infect Dis 61 2008 255 260
38. S. Homolka, C.G. Meyer, D. Hillemann, E. Owusu-Dabo, O. Adjei, R.D. Horstmann, E.N. Browne, A. Chinbuah, I. Osei, J. Gyapong, T. Kubica, S. Ruesch-Gerdes, and S. Niemann Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana Int J Med Microbiol 300 2010 489 495
39. M.V. Afanas'ev, L.N. Ikryannikova, E.N. Il'ina, S.V. Sidorenko, A.V. Kuz'min, E.E. Larionova, T.G. Smirnova, L.N. Chernousova, E.Y. Kamaev, S.N. Skorniakov, V.N. Kinsht, A.G. Cherednichenko, and V.M. Govorun Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation J Antimicrob Chemother 59 2007 1057 1064
40. U. Kozhamkulov, A. Akhmetova, S. Rakhimova, E. Belova, A. Alenova, V. Bismilda, L. Chingissova, S. Ismailov, E. Ramanculov, and K. Momynaliev Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan Jpn J Infect Dis 64 2011 253 255
41. H. Guo, Q. Seet, S. Denkin, L. Parsons, and Y. Zhang Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA J Med Microbiol 55 2006 1527 1531
42. S. Bolotin, D.C. Alexander, P. Chedore, S.J. Drews, and F. Jamieson Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada J Antimicrob Chemother 64 2009 263 266
43. N. Suresh, U.B. Singh, J. Arora, H. Pant, P. Seth, C. Sola, N. Rastogi, J.C. Samantaray, and J.N. Pande rpoB gene sequencing and spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates from India Infect Genet Evol 6 2006 474 483
44. A. Soudani, S. Hadjfredj, M. Zribi, F. Messaadi, T. Messaoud, A. Masmoudi, M. Zribi, and C. Fendri Genotypic and phenotypic characteristics of tunisian isoniazid-resistant Mycobacterium tuberculosis strains J Microbiol 49 2011 413 417
45. H. Valvatne, H. Syre, M. Kross, R. Stavrum, T. Ti, S. Phyu, and H.M. Grewal Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing Antimicrob Agents Chemother 64 2009 694 701
46. N. Siddiqi, M. Shamim, S. Hussain, R.K. Choudhary, N. Ahmed, Prachee, S. Banerjee, G.R. Savithri, M. Alam, N. Pathak, A. Amin, M. Hanief, V.M. Katoch, S.K. Sharma, and S.E. Hasnain Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in north India Antimicrob Agents Chemother 46 2002 443 450
47. A. Nusrath Unissa, N. Selvakumar, S. Narayanan, and P.R. Narayanan Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India Int J Antimicrob Agents 31 2008 71 75
48. J.P. Mathuria, G. Nath, J.K. Samaria, and S. Anupurba Molecular characterization of INH-resistant Mycobacterium tuberculosis isolates by PCR-RFLP and multiplex-PCR in north India Infect Genet Evol 9 2009 1352 1355
49. S. Banu, S.V. Gordon, S. Palmer, R. Islam, S. Ahmed, K.M. Khan Alam, S.T. Cole, and R. Roland Brosch Genotypic analysis of Mycobacterium tuberculosis in Bangladesh and prevalence of the Beijing strain J Clin Microbiol 42 2004 674 682
50. S. Banu, M.K.M. Uddin, M.R. Islam, K. Zaman, T. Ahmed, A.H. Talukder, M.T. Rahman, Z. Rahim, N. Akter, R. Khatun, R. Brosch, and H.P. Endtz Molecular epidemiology of tuberculosis in rural Matlab, Bangladesh Int J Tuberc Lung Dis 16 2012 319 326
51. S. Phyu, R. Jureen, T. Ti, U.R. Dahle, and H.M.S. Grewal Heterogeneity of Mycobacterium tuberculosis isolates in Yangon, Myanmar J Clin Microbiol 41 2003 4907 4908
52. U.B. Singh, N. Suresh, N.V. Bhanu, J. Arora, H. Pant, S. Sinha, R.C. Aggarwal, S. Singh, J.N. Pande, C. Sola, N. Rastogi, and P. Seth Predominant tuberculosis Spoligotypes, Delhi, India Emerg Infect Dis 10 2004 1138 1142
53. S. Narayanan, S. Gagneux, L. Hari, A.G. Tsolaki, S. Rajasekhar, P.R. Narayanan, P.M. Small, S. Holmes, and K. DeRiemer Genomic interrogation of ancestral Mycobacterium tuberculosis from south India Infect Genet Evol 8 2008 474 483